ARTICLE | Company News
4SC, Axxima cytomegalovirus deal
September 10, 2001 7:00 AM UTC
4SC (Martinsried, Germany) and Axxima Pharmaceuticals (Martinsried, Germany) will collaborate to develop small molecule kinase inhibitors to treat cytomegalovirus infections. The deal combines protein...